AngioNorm tablets p / o 100mg, No. 100

As part of the complex therapy of diseases accompanied by vascular disorders, such as increased platelet aggregation (thrombosis, thromboembolism), impaired capillary permeability and microcirculation (capillary thrombosis), impaired venous circulation (varicose veins, post-thrombotic syndrome, thrombophlebitis).

AngioNormЃ is taken orally 1 tablet 3 times a day 40 minutes after meals. The duration of the course of treatment is up to 3 weeks. It is possible to increase a single dose of AngioNormЃ up to 2 tablets 3 times a day in case of good tolerance. The need for a second course is determined by the doctor.

Each coated tablet contains:
Active ingredient: dry extract (obtained from a mixture of medicinal plant materials - hawthorn fruit, licorice roots, horse chestnut seeds, thorn-thorn fruit containing the sum of flavonoids in terms of avicularin 0.50 mg) - 100 mg.
Excipients: lactose monohydrate - 57.00 mg, potato starch - 89.00 mg, microcrystalline cellulose - 1.00 mg, stearic acid - 3.0 mg.
The shell obtained by the extension method: sucrose - 141.10 mg, magnesium hydroxycarbonate - 27.64 mg, colloidal silicon dioxide - 2.20 mg, titanium dioxide - 2.70 mg, low molecular weight povidone - 2.20 mg, talc - 1, 90 mg, dye tropeolin-O - 0.06 mg.
Gloss mastic: beeswax - 0.10 mg, liquid paraffin - 0.10 mg.

Description :

Hypersensitivity to the components of the drug, severe chronic diseases of the liver, kidneys and gastrointestinal tract with impairment of their functions. Lactase deficiency, lactose intolerance, sucrase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption (due to the presence of lactose and sucrose).
It is not recommended to prescribe the drug to children under the age of 18, during pregnancy and during breastfeeding due to the lack of data on the safety of clinical use.

Trade name:

AngioNormЃ

Dosage form:

coated tablets

Composition:

Each coated tablet contains:
Active ingredient: dry extract (obtained from a mixture of medicinal plant materials - hawthorn fruit, licorice roots, horse chestnut seeds, thorn-thorn fruit containing the sum of flavonoids in terms of avicularin 0.50 mg) - 100 mg.
Excipients: lactose monohydrate - 57.00 mg, potato starch - 89.00 mg, microcrystalline cellulose - 1.00 mg, stearic acid - 3.0 mg.
The shell obtained by the extension method: sucrose - 141.10 mg, magnesium hydroxycarbonate - 27.64 mg, colloidal silicon dioxide - 2.20 mg, titanium dioxide - 2.70 mg, low molecular weight povidone - 2.20 mg, talc - 1, 90 mg, dye tropeolin-O - 0.06 mg.
Gloss mastic: beeswax - 0.10 mg, liquid paraffin - 0.10 mg.

Description :

Tablets of a biconvex shape, coated with a yellow shell, the cut shows yellow and white shells, as well as the core of the tablet from light brown to dark brown, light inclusions are allowed.

Pharmacotherapeutic group:

Angioprotective agent.

ATX code : —10ј’

Pharmacological properties

AngioNormЃ has a pronounced antiaggregatory, antiplatelet activity, angioprotective and anti-inflammatory properties, has a venotonic and microcirculation-improving effect, activates the diuretic function of the kidneys.
AngioNormЃ has an effect on the general condition of the body: it increases physical performance, exhibits stress-protective activity and a moderate analgesic effect.

Indications for use

As part of the complex therapy of diseases accompanied by vascular disorders, such as increased platelet aggregation (thrombosis, thromboembolism), impaired capillary permeability and microcirculation (capillary thrombosis), impaired venous circulation (varicose veins, post-thrombotic syndrome, thrombophlebitis).

Contraindications

Hypersensitivity to the components of the drug, severe chronic diseases of the liver, kidneys and gastrointestinal tract with impairment of their functions. Lactase deficiency, lactose intolerance, sucrase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption (due to the presence of lactose and sucrose).
It is not recommended to prescribe the drug to children under the age of 18, during pregnancy and during breastfeeding due to the lack of data on the safety of clinical use.

Method of administration and dosage

AngioNormЃ is taken orally 1 tablet 3 times a day 40 minutes after meals. The duration of the course of treatment is up to 3 weeks. It is possible to increase a single dose of AngioNormЃ up to 2 tablets 3 times a day in case of good tolerance. The need for a second course is determined by the doctor.

Side effect

Allergic reactions, dyspeptic disorders.

Overdose

Long-term use of AngioNormЃ in doses exceeding the recommended daily dose may increase the severity of dose-dependent side effects. Treatment is symptomatic.

Interaction with other medicinal products

The use of AngioNormЃ can be combined with other drugs: lipid-lowering, anti-inflammatory, analgesic drugs, antibiotics, direct and indirect anticoagulants.

special instructions

The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions.
Information for patients with diabetes mellitus: one tablet contains 0.023 bread units (XE), in the maximum daily dose - 0.138 bread units (XE).

Release form:

100 mg film-coated tablets.
10 tablets in a blister strip made of polyvinyl chloride film and printed aluminum foil varnished or packaging paper with a polyethylene coating.
30 tablets in jars of light-shielding glass, or in polymer jars, or in plastic cases.
Each can, each pencil case, 1, 2 or 3 blister packs, together with instructions for use, are placed in a cardboard box.

Storage conditions

In a dry, dark place at a temperature of 15 ? C to 25 ? C.
Keep out of the reach of children.

Shelf life

5 years. Do not use after the expiration date printed on the package.

Conditions of dispensing from pharmacies

Without recipe.